• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑静脉血栓形成的管理进展

Update on management of cerebral venous thrombosis.

作者信息

Rosa Sara, Fragata Isabel, Aguiar de Sousa Diana

机构信息

Neuroradiology Department, Lisbon Central University Hospital - ULS São José.

Faculdade de Medicina, Universidade de Lisboa.

出版信息

Curr Opin Neurol. 2025 Feb 1;38(1):18-28. doi: 10.1097/WCO.0000000000001329. Epub 2024 Oct 21.

DOI:10.1097/WCO.0000000000001329
PMID:39469812
Abstract

PURPOSE OF REVIEW

This review intends to systematize the diagnostic and treatment approach to cerebral venous thrombosis (CVT), highlighting key studies that have been recently published.

RECENT FINDINGS

In light of the recent pandemic, new risk factors for CVT have emerged. Contrast-enhanced MRI and susceptibility-weighted imaging have been shown to offer increased sensitivity for detecting cortical vein thrombosis.Dabigatran seems to be as effective and well tolerated as warfarin for long-term anticoagulation. Partial venous recanalization often occurs in patients treated with anticoagulation only, as early as 8 days after treatment onset. For patients with CVT and impending brain herniation, two-thirds of those who undergo decompressive craniectomy survive, with one-third being functionally independent 6 months after diagnosis.

SUMMARY

CVT is an unusual type of cerebrovascular disease that mostly affects women of fertile age. Risk factors should be identified and addressed. Diagnosis relies on confirmation of venous sinus and/or vein thrombosis, usually by CT venography or MRI. Anticoagulation is the cornerstone of treatment. Despite the lack of high-quality evidence, endovascular treatment is often considered in severe cases. Special populations require tailored approaches. About 80% achieve mRS 0-1, but residual symptoms often affect quality of life and the ability to return to work.

摘要

综述目的

本综述旨在系统阐述脑静脉血栓形成(CVT)的诊断和治疗方法,重点介绍近期发表的关键研究。

最新发现

鉴于近期的大流行,CVT出现了新的危险因素。对比增强磁共振成像(MRI)和磁敏感加权成像已被证明在检测皮质静脉血栓形成方面具有更高的敏感性。达比加群在长期抗凝治疗中似乎与华法林一样有效且耐受性良好。仅接受抗凝治疗的患者通常早在治疗开始后8天就会出现部分静脉再通。对于患有CVT且即将发生脑疝的患者,三分之二接受减压颅骨切除术的患者存活,三分之一在诊断后6个月功能独立。

总结

CVT是一种不常见的脑血管疾病,主要影响育龄女性。应识别并处理危险因素。诊断通常依靠CT静脉造影或MRI确认静脉窦和/或静脉血栓形成。抗凝是治疗的基石。尽管缺乏高质量证据,但在严重病例中常考虑血管内治疗。特殊人群需要量身定制的方法。约80%的患者改良Rankin量表(mRS)评分为0 - 1,但残留症状常影响生活质量和重返工作岗位的能力。

相似文献

1
Update on management of cerebral venous thrombosis.脑静脉血栓形成的管理进展
Curr Opin Neurol. 2025 Feb 1;38(1):18-28. doi: 10.1097/WCO.0000000000001329. Epub 2024 Oct 21.
2
Cerebral Venous Thrombosis: an Update.脑静脉血栓形成:最新进展。
Curr Neurol Neurosci Rep. 2019 Aug 23;19(10):74. doi: 10.1007/s11910-019-0988-x.
3
Evaluation and management of cerebral venous thrombosis.脑静脉血栓形成的评估与管理
Continuum (Minneap Minn). 2014 Apr;20(2 Cerebrovascular Disease):335-51. doi: 10.1212/01.CON.0000446105.67173.a8.
4
Cerebral Venous Thrombosis.脑静脉血栓形成
Adv Exp Med Biol. 2017;906:183-193. doi: 10.1007/5584_2016_115.
5
Cerebral venous thrombosis.脑静脉血栓形成。
J Thromb Haemost. 2015 Jun;13 Suppl 1:S238-44. doi: 10.1111/jth.12945.
6
Cerebral venous thrombosis.脑静脉血栓形成。
Minerva Med. 2021 Dec;112(6):755-766. doi: 10.23736/S0026-4806.21.07353-5. Epub 2021 Feb 8.
7
Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.达比加群酯与剂量调整华法林治疗颅内静脉血栓形成患者的安全性和有效性:一项随机临床试验。
JAMA Neurol. 2019 Dec 1;76(12):1457-1465. doi: 10.1001/jamaneurol.2019.2764.
8
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.直接口服抗凝剂与华法林治疗脑静脉血栓形成(ACTION-CVT)的多中心国际研究。
Stroke. 2022 Mar;53(3):728-738. doi: 10.1161/STROKEAHA.121.037541. Epub 2022 Feb 10.
9
European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology.欧洲卒中组织脑静脉血栓形成诊断与治疗指南- 欧洲神经病学学会认可。
Eur J Neurol. 2017 Oct;24(10):1203-1213. doi: 10.1111/ene.13381. Epub 2017 Aug 20.
10
Cerebral Venous Thrombosis Associated with Intracranial Hemorrhage and Timing of Anticoagulation after Hemicraniectomy.与颅内出血相关的脑静脉血栓形成及颅骨切除术后脑抗凝时机
J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2312-6. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.025. Epub 2016 Jun 16.

引用本文的文献

1
Diagnostic value of MR black-blood thrombus imaging, contrast-enhanced MRI, and noncontrast-enhanced MR venography in cerebral vein thrombosis: a systematic review and meta-analysis.磁共振黑血血栓成像、对比增强磁共振成像及非对比增强磁共振静脉成像在脑静脉血栓形成中的诊断价值:一项系统评价和荟萃分析
Eur Radiol. 2025 Aug 28. doi: 10.1007/s00330-025-11965-8.
2
Cerebral Venous Thrombosis: Selected Persisting Areas of Uncertainty.脑静脉血栓形成:选定的持续存在的不确定性领域。
Ann Indian Acad Neurol. 2025 May 1;28(3):307-313. doi: 10.4103/aian.aian_162_25. Epub 2025 May 27.
3
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update.
直接口服抗凝剂治疗罕见部位静脉血栓形成:最新进展
Pharmaceutics. 2025 Mar 7;17(3):342. doi: 10.3390/pharmaceutics17030342.